TuHURA Dividend Paid And Capex Coverage Ratio from 2010 to 2024
| HURA Stock | 4.93 0.45 8.36% |
Dividend Paid And Capex Coverage Ratio | First Reported 2010-12-31 | Previous Quarter (150.85) | Current Value (158.39) | Quarterly Volatility 621.17483631 |
Check TuHURA Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TuHURA Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 264.9 K, Interest Expense of 17.8 K or Other Operating Expenses of 18.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. TuHURA financial statements analysis is a perfect complement when working with TuHURA Biosciences Valuation or Volatility modules.
TuHURA | Dividend Paid And Capex Coverage Ratio |
Latest TuHURA Biosciences' Dividend Paid And Capex Coverage Ratio Growth Pattern
Below is the plot of the Dividend Paid And Capex Coverage Ratio of TuHURA Biosciences over the last few years. It is TuHURA Biosciences' Dividend Paid And Capex Coverage Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TuHURA Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Dividend Paid And Capex Coverage Ratio | 10 Years Trend |
|
Dividend Paid And Capex Coverage Ratio |
| Timeline |
TuHURA Dividend Paid And Capex Coverage Ratio Regression Statistics
| Arithmetic Mean | (469.20) | |
| Coefficient Of Variation | (132.39) | |
| Mean Deviation | 516.69 | |
| Median | (150.85) | |
| Standard Deviation | 621.17 | |
| Sample Variance | 385,858 | |
| Range | 2K | |
| R-Value | (0.38) | |
| Mean Square Error | 356,861 | |
| R-Squared | 0.14 | |
| Significance | 0.17 | |
| Slope | (52.20) | |
| Total Sum of Squares | 5.4M |
TuHURA Dividend Paid And Capex Coverage Ratio History
About TuHURA Biosciences Financial Statements
TuHURA Biosciences stakeholders use historical fundamental indicators, such as TuHURA Biosciences' Dividend Paid And Capex Coverage Ratio, to determine how well the company is positioned to perform in the future. Although TuHURA Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in TuHURA Biosciences' assets and liabilities are reflected in the revenues and expenses on TuHURA Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in TuHURA Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | (150.85) | (158.39) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TuHURA Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TuHURA Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tuhura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tuhura Biosciences Stock:Check out the analysis of TuHURA Biosciences Correlation against competitors. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. If investors know TuHURA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TuHURA Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of TuHURA Biosciences is measured differently than its book value, which is the value of TuHURA that is recorded on the company's balance sheet. Investors also form their own opinion of TuHURA Biosciences' value that differs from its market value or its book value, called intrinsic value, which is TuHURA Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TuHURA Biosciences' market value can be influenced by many factors that don't directly affect TuHURA Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TuHURA Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.